A Bullish Prognosis for Global Healthcare ETFs [View article]
Looks like HQL would appeal to investors looking for higher risk/reward investments in the healthcare sector. Has about 60% invested in biopharma, med devices & diagnostics. Of the top holdings Biomarin (BMRN) has done very well while Acadia Pharma (ACAD) is the worst performer. The fund trades at 15% discount to its NAV with a 9.4% distribution rate. See the full profile at www.etfconnect.com/sel...
-
Looks like HQL would appeal to investors looking for higher risk/reward investments in the healthcare sector. Has about 60% invested in biopharma, med devices & diagnostics. Of the top holdings Biomarin (BMRN) has done very well while Acadia Pharma (ACAD) is the worst performer. The fund trades at 15% discount to its NAV with a 9.4% distribution rate. See the full profile at www.etfconnect.com/sel...
Jul 13 13:16 pm
|Rating:
0
0
All Comments by Mike Havrilla »A Bullish Prognosis for Global Healthcare ETFs [View article]